Order Article Reprints

Qian X, Liu Y, Wu F, Zhang S, Gong J, Nan Y, Hu B, Chen J, Zhao J, Chen X, et al. The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients. Viruses. 2022; 14(8):1669. https://doi.org/10.3390/v14081669

Qian, Xiangjun, Yanna Liu, Fengping Wu, Siyu Zhang, Jiao Gong, Yuemin Nan, Bo Hu, Junhui Chen, Jingmin Zhao, Xiangmei Chen, and et al. 2022. "The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients" Viruses 14, no. 8: 1669. https://doi.org/10.3390/v14081669

Qian, X., Liu, Y., Wu, F., Zhang, S., Gong, J., Nan, Y., Hu, B., Chen, J., Zhao, J., Chen, X., Pan, W., Dang, S., & Lu, F. (2022). The Performance of Serum Alpha-Fetoprotein for Detecting Early-Stage Hepatocellular Carcinoma Is Influenced by Antiviral Therapy and Serum Aspartate Aminotransferase: A Study in a Large Cohort of Hepatitis B Virus-Infected Patients. Viruses, 14(8), 1669. https://doi.org/10.3390/v14081669